Thomas Stöhr - Concepedia

Author

Thomas Stöhr

Paion (Germany)ORCID

Also Known As

Stöhr, Thomas, T Stöhr, T. Stohr, T. Stöhr, Thomas Stohr, Thomas Stöhr, Thomas Stöhr

Publications

4.9K

Citations

H-Index

146

Concepts

All Affiliations

Paion (Germany)Ablynx (Belgium)Rohde & Schwarz (Germany)Max Planck Institute of Psychiatry École Polytechnique Fédérale de Lausanne

About

Thomas Stöhr is an author at Paion (Germany) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.9K
2	Health Sciences	7	7	455
3	Engineering	5	5	143
4	Public Health	2	2	304
5	Natural Sciences	1	1	31

Thomas Stöhr

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Animal models in translational medicine: Validation and prediction Tinneke Denayer, Thomas Stöhr, Maarten Van Roy European Journal of Molecular & Clinical Medicine Translational MedicineXenotransplantationPreclinical Drug EvaluationClinical TranslationTranslational Relevance	2014	440
The Investigational Anticonvulsant Lacosamide Selectively Enhances Slow Inactivation of Voltage-Gated Sodium Channels Adam C. Errington, Thomas Stöhr, Cara Heers, Molecular Pharmacology	2007	431
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection Laurent Detalle, Thomas Stöhr, Concepción Palomo, Antimicrobial Agents and Chemotherapy	2015	289
Long-term effects of prenatal stress experience and postnatal maternal separation on emotionality and attentional processes Julia Lehmann, Thomas Stöhr, Joram Feldon Behavioural Brain Research Behavioral SciencesLong-term EffectsEmotion RegulationPostnatal Maternal SeparationAffective Neuroscience	2000	217
Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment Thomas Stöhr, Pieter Colin, Joachim Ossig, British Journal of Anaesthesia	2021	192
Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy Thomas Stöhr, Harvey J. Kupferberg, James P. Stables, Epilepsy Research Neuromodulation (Medicine)MedicineWide Safety MarginPsychotropic MedicationRodent Models	2007	154
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura Filip Callewaert, Jan Roodt, Hans Ulrichts, Blood	2012	140
Seeking a mechanism of action for the novel anticonvulsant lacosamide Adam C. Errington, Leanne Coyne, Thomas Stöhr, Neuropharmacology Molecular PharmacologyMedicinal ChemistryMedicineMechanism Of ActionPharmacological Agent	2006	132
Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy B. Beyreuther, Noëlle Callizot, Thomas Stöhr European Journal of Pharmacology Pain SyndromePain MedicineMedicineDiabetesDiabetic Neuropathy	2006	109
Lewis/Fischer rat strain differences in endocrine and behavioural responses to environmental challenge Thomas Stöhr, Thomas F. Szuran, Hans Welzl, Pharmacology Biochemistry and Behavior BiologyAnimal PhysiologyEnvironmental ChallengeBehavioural ResponsesFitness	2000	101

Page 1